B. Metzler seel. Sohn & Co’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.31M | Sell |
55,145
-10,962
| -17% | -$857K | 0.04% | 215 |
|
2025
Q1 | $4.79M | Buy |
66,107
+2,461
| +4% | +$178K | 0.05% | 184 |
|
2024
Q4 | $4.71M | Sell |
63,646
-16,712
| -21% | -$1.24M | 0.05% | 183 |
|
2024
Q3 | $5.3M | Sell |
80,358
-7,803
| -9% | -$515K | 0.05% | 185 |
|
2024
Q2 | $8.14M | Buy |
88,161
+9,161
| +12% | +$846K | 0.08% | 120 |
|
2024
Q1 | $7.47M | Buy |
79,000
+11,678
| +17% | +$1.1M | 0.08% | 127 |
|
2023
Q4 | $5.13M | Buy |
67,322
+7,724
| +13% | +$589K | 0.07% | 176 |
|
2023
Q3 | $4.13M | Sell |
59,598
-52,569
| -47% | -$3.64M | 0.06% | 189 |
|
2023
Q2 | $10.6M | Buy |
112,167
+61,293
| +120% | +$5.78M | 0.14% | 97 |
|
2023
Q1 | $4.21M | Hold |
50,874
| – | – | 0.07% | 179 |
|
2022
Q4 | $3.8M | Sell |
50,874
-33,204
| -39% | -$2.48M | 0.06% | 191 |
|
2022
Q3 | $6.95M | Sell |
84,078
-1,883
| -2% | -$156K | 0.13% | 117 |
|
2022
Q2 | $8.17M | Buy |
85,961
+10,260
| +14% | +$976K | 0.13% | 112 |
|
2022
Q1 | $8.91M | Sell |
75,701
-3,196
| -4% | -$376K | 0.12% | 124 |
|
2021
Q4 | $10.3M | Buy |
78,897
+13,522
| +21% | +$1.77M | 0.13% | 107 |
|
2021
Q3 | $7.4M | Sell |
65,375
-938
| -1% | -$106K | 0.11% | 119 |
|
2021
Q2 | $6.87M | Buy |
66,313
+960
| +1% | +$99.4K | 0.1% | 127 |
|
2021
Q1 | $5.47M | Buy |
65,353
+6,345
| +11% | +$531K | 0.09% | 143 |
|
2020
Q4 | $5.51M | Buy |
+59,008
| New | +$5.51M | 0.1% | 125 |
|